Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 15806 | 30.65 |
09:34 ET | 2344 | 30.6 |
09:36 ET | 1500 | 30.62 |
09:38 ET | 22417 | 30.645 |
09:39 ET | 6918 | 30.625 |
09:41 ET | 7817 | 30.59 |
09:43 ET | 5259 | 30.56 |
09:45 ET | 4514 | 30.57 |
09:48 ET | 44032 | 30.59 |
09:50 ET | 10958 | 30.55 |
09:52 ET | 12414 | 30.54 |
09:54 ET | 3839 | 30.54 |
09:56 ET | 1200 | 30.51 |
09:57 ET | 2755 | 30.515 |
09:59 ET | 3051 | 30.54 |
10:01 ET | 2651 | 30.5525 |
10:03 ET | 2790 | 30.52 |
10:06 ET | 3119 | 30.525 |
10:08 ET | 1613 | 30.54 |
10:10 ET | 2000 | 30.5 |
10:12 ET | 1526 | 30.505 |
10:14 ET | 1700 | 30.52 |
10:15 ET | 2854 | 30.52 |
10:17 ET | 5338 | 30.51 |
10:19 ET | 2700 | 30.525 |
10:21 ET | 2700 | 30.525 |
10:24 ET | 2925 | 30.56 |
10:26 ET | 2974 | 30.53 |
10:28 ET | 2690 | 30.58 |
10:30 ET | 668 | 30.575 |
10:32 ET | 8246 | 30.51 |
10:33 ET | 2122 | 30.51 |
10:35 ET | 16692 | 30.51 |
10:37 ET | 6961 | 30.505 |
10:39 ET | 12656 | 30.525 |
10:42 ET | 11688 | 30.525 |
10:44 ET | 5378 | 30.52 |
10:46 ET | 1500 | 30.55 |
10:48 ET | 1665 | 30.5975 |
10:50 ET | 4225 | 30.58 |
10:51 ET | 2759 | 30.59 |
10:53 ET | 800 | 30.59 |
10:55 ET | 16082 | 30.555 |
10:57 ET | 2656 | 30.57 |
11:00 ET | 2678 | 30.56 |
11:02 ET | 6095 | 30.56 |
11:04 ET | 30610 | 30.61 |
11:06 ET | 717 | 30.61 |
11:08 ET | 4200 | 30.61 |
11:09 ET | 3950 | 30.61 |
11:11 ET | 1908 | 30.62 |
11:13 ET | 5514 | 30.62 |
11:15 ET | 39490 | 30.685 |
11:18 ET | 5688 | 30.725 |
11:20 ET | 2100 | 30.745 |
11:22 ET | 13713 | 30.745 |
11:24 ET | 3700 | 30.76 |
11:26 ET | 2768 | 30.76 |
11:27 ET | 1464 | 30.77 |
11:29 ET | 800 | 30.79 |
11:31 ET | 2600 | 30.76 |
11:33 ET | 8702 | 30.73 |
11:36 ET | 1409 | 30.72 |
11:38 ET | 1933 | 30.72 |
11:40 ET | 613 | 30.72 |
11:42 ET | 2100 | 30.67 |
11:44 ET | 1240 | 30.65 |
11:45 ET | 2845 | 30.625 |
11:47 ET | 1164 | 30.61 |
11:49 ET | 6525 | 30.61 |
11:51 ET | 2933 | 30.61 |
11:54 ET | 2016 | 30.625 |
11:56 ET | 2000 | 30.64 |
11:58 ET | 3542 | 30.63 |
12:00 ET | 1291 | 30.6112 |
12:02 ET | 1226 | 30.63 |
12:03 ET | 2800 | 30.62 |
12:05 ET | 600 | 30.61 |
12:07 ET | 1615 | 30.615 |
12:09 ET | 200 | 30.62 |
12:12 ET | 4564 | 30.585 |
12:14 ET | 1662 | 30.57 |
12:16 ET | 464 | 30.57 |
12:18 ET | 3304 | 30.605 |
12:20 ET | 3312 | 30.59 |
12:21 ET | 1628 | 30.6 |
12:23 ET | 2000 | 30.59 |
12:25 ET | 1521 | 30.58 |
12:27 ET | 1400 | 30.57 |
12:30 ET | 400 | 30.57 |
12:32 ET | 1100 | 30.55 |
12:34 ET | 5890 | 30.53 |
12:36 ET | 3842 | 30.5 |
12:38 ET | 16921 | 30.47 |
12:39 ET | 6300 | 30.495 |
12:41 ET | 1300 | 30.49 |
12:43 ET | 2800 | 30.5 |
12:45 ET | 3800 | 30.56 |
12:48 ET | 3208 | 30.5 |
12:50 ET | 17040 | 30.505 |
12:52 ET | 10975 | 30.5 |
12:54 ET | 2300 | 30.5 |
12:56 ET | 2660 | 30.485 |
12:57 ET | 7626 | 30.5 |
12:59 ET | 200 | 30.5 |
01:01 ET | 8429 | 30.5 |
01:03 ET | 700 | 30.5 |
01:06 ET | 4994 | 30.51 |
01:08 ET | 1000 | 30.55 |
01:10 ET | 708 | 30.54 |
01:12 ET | 1431 | 30.58 |
01:14 ET | 800 | 30.5725 |
01:15 ET | 1900 | 30.53 |
01:17 ET | 8205 | 30.495 |
01:19 ET | 14083 | 30.505 |
01:21 ET | 3220 | 30.5 |
01:24 ET | 1515 | 30.5 |
01:26 ET | 500 | 30.5025 |
01:28 ET | 3200 | 30.53 |
01:30 ET | 3153 | 30.55 |
01:32 ET | 1286 | 30.55 |
01:33 ET | 1327 | 30.56 |
01:35 ET | 2943 | 30.51 |
01:37 ET | 900 | 30.525 |
01:39 ET | 1316 | 30.53 |
01:42 ET | 300 | 30.535 |
01:44 ET | 1803 | 30.53 |
01:46 ET | 900 | 30.53 |
01:48 ET | 500 | 30.535 |
01:50 ET | 5319 | 30.52 |
01:51 ET | 1961 | 30.5 |
01:53 ET | 200 | 30.5 |
01:55 ET | 1094 | 30.49 |
01:57 ET | 3091 | 30.485 |
02:00 ET | 1942 | 30.49 |
02:02 ET | 2554 | 30.49 |
02:04 ET | 2141 | 30.485 |
02:06 ET | 1636 | 30.485 |
02:08 ET | 3000 | 30.525 |
02:09 ET | 2669 | 30.52 |
02:11 ET | 600 | 30.53 |
02:13 ET | 3000 | 30.49 |
02:15 ET | 1664 | 30.51 |
02:18 ET | 2603 | 30.49 |
02:20 ET | 1745 | 30.51 |
02:22 ET | 3302 | 30.5 |
02:24 ET | 1970 | 30.515 |
02:26 ET | 2361 | 30.515 |
02:27 ET | 1447 | 30.505 |
02:29 ET | 257 | 30.505 |
02:31 ET | 1450 | 30.495 |
02:33 ET | 2779 | 30.495 |
02:36 ET | 1681 | 30.5 |
02:38 ET | 2401 | 30.485 |
02:40 ET | 963 | 30.4807 |
02:42 ET | 600 | 30.495 |
02:44 ET | 2840 | 30.485 |
02:45 ET | 1000 | 30.4968 |
02:47 ET | 624 | 30.49 |
02:49 ET | 1393 | 30.49 |
02:51 ET | 400 | 30.495 |
02:54 ET | 7147 | 30.48 |
02:56 ET | 3600 | 30.49 |
02:58 ET | 1943 | 30.525 |
03:00 ET | 5911 | 30.52 |
03:02 ET | 1500 | 30.53 |
03:03 ET | 6270 | 30.505 |
03:05 ET | 2130 | 30.49 |
03:07 ET | 1170 | 30.5 |
03:09 ET | 3753 | 30.5 |
03:12 ET | 8050 | 30.47 |
03:14 ET | 1200 | 30.49 |
03:16 ET | 800 | 30.49 |
03:18 ET | 4498 | 30.49 |
03:20 ET | 1578 | 30.495 |
03:21 ET | 600 | 30.495 |
03:23 ET | 5246 | 30.465 |
03:25 ET | 31656 | 30.45 |
03:27 ET | 24275 | 30.45 |
03:30 ET | 19703 | 30.45 |
03:32 ET | 12031 | 30.45 |
03:34 ET | 6940 | 30.45 |
03:36 ET | 2798 | 30.45 |
03:38 ET | 4500 | 30.44 |
03:39 ET | 1924 | 30.42 |
03:41 ET | 6862 | 30.435 |
03:43 ET | 13315 | 30.435 |
03:45 ET | 5648 | 30.435 |
03:48 ET | 3902 | 30.435 |
03:50 ET | 7571 | 30.415 |
03:52 ET | 52379 | 30.49 |
03:54 ET | 33767 | 30.44 |
03:56 ET | 134551 | 30.335 |
03:57 ET | 40968 | 30.39 |
03:59 ET | 78941 | 30.37 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 18.1B | 12.0x | +1.83% |
Catalent Inc | 10.2B | -7.9x | --- |
Jazz Pharmaceuticals PLC | 7.5B | 19.7x | -3.53% |
Endo International PLC | 94.1K | 0.0x | --- |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.6B | -44.2x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $18.1B |
---|---|
Revenue (TTM) | $2.4B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.77% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 02-15-24 |
Pay Date | 03-15-24 |
Beta | 0.45 |
EPS | $2.54 |
Book Value | $14.61 |
P/E Ratio | 12.0x |
Price/Sales (TTM) | 7.7 |
Price/Cash Flow (TTM) | 10.7x |
Operating Margin | 63.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.